Mesa Laboratories Statistics
Total Valuation
MLAB has a market cap or net worth of $700.38 million. The enterprise value is $829.49 million.
| Market Cap | 700.38M |
| Enterprise Value | 829.49M |
Important Dates
The next confirmed earnings date is Monday, November 9, 2026, after market close.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | Nov 30, 2026 |
Share Statistics
MLAB has 5.60 million shares outstanding. The number of shares has increased by 3.27% in one year.
| Current Share Class | 5.60M |
| Shares Outstanding | 5.60M |
| Shares Change (YoY) | +3.27% |
| Shares Change (QoQ) | +3.84% |
| Owned by Insiders (%) | 3.10% |
| Owned by Institutions (%) | 87.47% |
| Float | 4.95M |
Valuation Ratios
The trailing PE ratio is 145.39 and the forward PE ratio is 56.51.
| PE Ratio | 145.39 |
| Forward PE | 56.51 |
| PS Ratio | 2.80 |
| Forward PS | 2.73 |
| PB Ratio | 3.71 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.25 |
| P/OCF Ratio | 12.58 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.26, with an EV/FCF ratio of 15.69.
| EV / Earnings | 172.81 |
| EV / Sales | 3.32 |
| EV / EBITDA | 18.26 |
| EV / EBIT | 36.90 |
| EV / FCF | 15.69 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.85.
| Current Ratio | 1.79 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 3.05 |
| Debt / FCF | 3.05 |
| Interest Coverage | 2.07 |
Financial Efficiency
Return on equity (ROE) is 2.66% and return on invested capital (ROIC) is 3.58%.
| Return on Equity (ROE) | 2.66% |
| Return on Assets (ROA) | 3.29% |
| Return on Invested Capital (ROIC) | 3.58% |
| Return on Capital Employed (ROCE) | 6.21% |
| Weighted Average Cost of Capital (WACC) | 8.81% |
| Revenue Per Employee | $348,291 |
| Profits Per Employee | $6,695 |
| Employee Count | 717 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 3.23 |
Taxes
In the past 12 months, MLAB has paid $4.56 million in taxes.
| Income Tax | 4.56M |
| Effective Tax Rate | 48.69% |
Stock Price Statistics
The stock price has increased by +71.28% in the last 52 weeks. The beta is 1.05, so MLAB's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | +71.28% |
| 50-Day Moving Average | 125.71 |
| 200-Day Moving Average | 102.40 |
| Relative Strength Index (RSI) | 46.85 |
| Average Volume (20 Days) | 108,225 |
Short Selling Information
The latest short interest is 447,048, so 7.99% of the outstanding shares have been sold short.
| Short Interest | 447,048 |
| Short Previous Month | 403,559 |
| Short % of Shares Out | 7.99% |
| Short % of Float | 9.04% |
| Short Ratio (days to cover) | 3.41 |
Income Statement
In the last 12 months, MLAB had revenue of $249.73 million and earned $4.80 million in profits. Earnings per share was $0.86.
| Revenue | 249.73M |
| Gross Profit | 160.34M |
| Operating Income | 22.48M |
| Pretax Income | 9.36M |
| Net Income | 4.80M |
| EBITDA | 45.44M |
| EBIT | 22.48M |
| Earnings Per Share (EPS) | $0.86 |
Balance Sheet
The company has $32.24 million in cash and $161.35 million in debt, with a net cash position of -$129.11 million or -$23.07 per share.
| Cash & Cash Equivalents | 32.24M |
| Total Debt | 161.35M |
| Net Cash | -129.11M |
| Net Cash Per Share | -$23.07 |
| Equity (Book Value) | 188.76M |
| Book Value Per Share | 33.73 |
| Working Capital | 45.53M |
Cash Flow
In the last 12 months, operating cash flow was $55.67 million and capital expenditures -$2.80 million, giving a free cash flow of $52.87 million.
| Operating Cash Flow | 55.67M |
| Capital Expenditures | -2.80M |
| Depreciation & Amortization | 22.96M |
| Net Borrowing | -38.47M |
| Free Cash Flow | 52.87M |
| FCF Per Share | $9.45 |
Margins
Gross margin is 64.21%, with operating and profit margins of 9.00% and 1.92%.
| Gross Margin | 64.21% |
| Operating Margin | 9.00% |
| Pretax Margin | 3.75% |
| Profit Margin | 1.92% |
| EBITDA Margin | 18.19% |
| EBIT Margin | 9.00% |
| FCF Margin | 21.17% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 0.51%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 0.51% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 74.35% |
| FCF Payout Ratio | 6.77% |
| Buyback Yield | -3.27% |
| Shareholder Yield | -2.76% |
| Earnings Yield | 0.69% |
| FCF Yield | 7.55% |
Analyst Forecast
The average price target for MLAB is $117.50, which is -6.12% lower than the current price. The consensus rating is "Buy".
| Price Target | $117.50 |
| Price Target Difference | -6.12% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MLAB has an Altman Z-Score of 1.49 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.49 |
| Piotroski F-Score | 7 |